Review decisions
Showing 960 results of 2627 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00816
Product Type: Drug
Control Number: 240496
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-06-12
Decision / Authorization Date: 2021-05-26
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00825
Product Type: Drug
Control Number: 244266
DIN(s): 02516233
Manufacturer: Celgene Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-09-22
Decision / Authorization Date: 2021-05-26
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00882
Product Type: Drug
Control Number: 238175
DIN(s): 02516241, 02516268
Manufacturer: Endo Ventures Ltd.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2020-04-06
Decision / Authorization Date: 2021-05-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00603
Product Type: Drug
Control Number: 253111
DIN(s): 02527049
Manufacturer: Pfizer Canada ULC., on behalf of BioNTech Manufacturing GmbH
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-05-25
Issued / Original Publication Date: 2022-08-31
Decision / Authorization Date: 2022-05-09
Updated Date: 2025-11-20
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00858
Product Type: Drug
Control Number: 240953
Manufacturer: Gilead Sciences Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-06-23
Decision / Authorization Date: 2021-05-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00811
Product Type: Drug
Control Number: 240691
Manufacturer: Octapharma Pharmazeutika Produktionsges m.b.H.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-06-16
Decision / Authorization Date: 2021-05-19
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00820
Product Type: Drug
Control Number: 224036
DIN(s): 02516098
Manufacturer: Sun Pharma Global FZE
Submission Type: New Drug Submission
Date Filed / Submission Date: 2019-01-25
Decision / Authorization Date: 2021-05-19
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00267
Issued / Original Publication Date: 2021-05-19
Updated Date: 2021-06-09
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00873
Product Type: Drug
Control Number: 240171
DIN(s): 02476991
Manufacturer: Pfizer Canada ULC., on behalf of BioNTech Manufacturing GmbH
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-05-29
Decision / Authorization Date: 2021-05-18
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00867
Product Type: Drug
Control Number: 240101
Manufacturer: GlaxoSmithKline Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-05-28
Decision / Authorization Date: 2021-05-11